MONTREAL, March 31 /CNW Telbec/ - PainCeptor Pharma, a privately held
Canadian biotechnology company specializing in the development of therapeutic
compounds for the treatment of acute and chronic pain, announced today the
appointment of Dr. Francine Gervais, Ph. D., to the position of Senior Vice-
President and Vice-President of Pharmaceutical Development.
